Paying users zone. Data is covered by 
.
Get to Amgen Inc. for $19.99, or
get to entire website for at least 3 months from $49.99.
Income Statement
Quarterly Data
Difficulty: Beginner
The income statement presents information on the financial results of a company’s business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.
Amgen Inc., Consolidated Income Statement (quarterly data)
USD $ in millions
Based on: 10-Q (filing date: 2018-10-31), 10-Q (filing date: 2018-07-27), 10-Q (filing date: 2018-04-25), 10-K (filing date: 2018-02-13), 10-Q (filing date: 2017-10-26), 10-Q (filing date: 2017-07-26), 10-Q (filing date: 2017-04-27), 10-K (filing date: 2017-02-14), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-29), 10-Q (filing date: 2016-05-02), 10-K (filing date: 2016-02-16), 10-Q (filing date: 2015-11-02), 10-Q (filing date: 2015-08-05), 10-Q (filing date: 2015-04-27), 10-K (filing date: 2015-02-19), 10-Q (filing date: 2014-10-29), 10-Q (filing date: 2014-08-05), 10-Q (filing date: 2014-04-30), 10-K (filing date: 2014-02-24), 10-Q (filing date: 2013-10-29), 10-Q (filing date: 2013-08-06), 10-Q (filing date: 2013-05-03).
| Item | Description | The company |
|---|---|---|
| Product sales | Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. | Amgen Inc.’s product sales increased from Q1 2018 to Q2 2018 but then slightly declined from Q2 2018 to Q3 2018 not reaching Q1 2018 level. |
| Operating income | The net result for the period of deducting operating expenses from operating revenues. | Amgen Inc.’s operating income increased from Q1 2018 to Q2 2018 but then declined significantly from Q2 2018 to Q3 2018. |
| Income before income taxes | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | Amgen Inc.’s income before income taxes increased from Q1 2018 to Q2 2018 but then declined significantly from Q2 2018 to Q3 2018. |
| Net income | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | Amgen Inc.’s net income declined from Q1 2018 to Q2 2018 and from Q2 2018 to Q3 2018. |
